My Quote Request
6505-01-094-7542
20 Products
NDC00904-3365-61
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
NDC00904-3365-61
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
MFG
MAJOR PHARMACEUTICALS INC
Description
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACLOFEN TABLETS USP 10MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 10.000 MILLIGAMS BACLOFEN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,CIBA-GEIGY
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
LIORESAL TABLETS
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
LIORESAL TABLETS
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACLOFEN TABLETS USP 10MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 10.000 MILLIGAMS BACLOFEN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,CIBA-GEIGY
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00028-0023-61
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
NDC00028-0023-61
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACLOFEN TABLETS USP 10MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 10.000 MILLIGAMS BACLOFEN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,CIBA-GEIGY
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00173-4096-60
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
NDC00173-4096-60
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
MFG
ZENITH LABORATORIES INC
Description
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACLOFEN TABLETS USP 10MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 10.000 MILLIGAMS BACLOFEN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,CIBA-GEIGY
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00591-5730-01
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
NDC00591-5730-01
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
MFG
DANBURY PHARMACAL INC
Description
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACLOFEN TABLETS USP 10MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 10.000 MILLIGAMS BACLOFEN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,CIBA-GEIGY
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00832-1024-00
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
NDC00832-1024-00
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505010947542
NSN
6505-01-094-7542
MFG
PHARMACEUTICAL BASICS INC
Description
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACLOFEN TABLETS USP 10MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 10.000 MILLIGAMS BACLOFEN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,CIBA-GEIGY
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NEDOX
OXYGEN,USP
NSN, MFG P/N
6505010948399
NSN
6505-01-094-8399
MFG
SELOX OF ALABAMA INC
Description
III CUBIC MEASURE: 240.000 CUBIC FEET
SPECIAL FEATURES: FOR AMBULANCE AND MEDICAL SERVICE
MYLICON
SIMETHICONE TABLETS,USP
NSN, MFG P/N
6505010948891
NSN
6505-01-094-8891
MFG
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS DIMETHICONE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS;SCORING CHARACTERISTIC:HALF-SCORED;
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00038-0450-39
SIMETHICONE TABLETS,USP
NSN, MFG P/N
6505010948891
NSN
6505-01-094-8891
NDC00038-0450-39
SIMETHICONE TABLETS,USP
NSN, MFG P/N
6505010948891
NSN
6505-01-094-8891
MFG
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS DIMETHICONE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS;SCORING CHARACTERISTIC:HALF-SCORED;
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
DEPAKENE
VALPROATE SODIUM SYRUP
NSN, MFG P/N
6505010949241
NSN
6505-01-094-9241
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS VALPROIC ACID EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VALPROATE SODIUM SYRUP EQUIV TO 250MG VALPROIC ACID/5ML 1PT (473ML)
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS OR 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 250 MG VALPROATE ACID PER 5 ML
Related Searches:
DEPAKENE SYRUP
VALPROATE SODIUM SYRUP
NSN, MFG P/N
6505010949241
NSN
6505-01-094-9241
DEPAKENE SYRUP
VALPROATE SODIUM SYRUP
NSN, MFG P/N
6505010949241
NSN
6505-01-094-9241
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS VALPROIC ACID EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VALPROATE SODIUM SYRUP EQUIV TO 250MG VALPROIC ACID/5ML 1PT (473ML)
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS OR 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 250 MG VALPROATE ACID PER 5 ML
Related Searches:
NDC00074-5682-16
VALPROATE SODIUM SYRUP
NSN, MFG P/N
6505010949241
NSN
6505-01-094-9241
NDC00074-5682-16
VALPROATE SODIUM SYRUP
NSN, MFG P/N
6505010949241
NSN
6505-01-094-9241
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS VALPROIC ACID EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VALPROATE SODIUM SYRUP EQUIV TO 250MG VALPROIC ACID/5ML 1PT (473ML)
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS OR 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 250 MG VALPROATE ACID PER 5 ML
Related Searches:
NDC00005-3292-62
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010950217
NSN
6505-01-095-0217
NDC00005-3292-62
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010950217
NSN
6505-01-095-0217
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;FEATURES PROVIDED:TAMPER PROOF CAP;
Related Searches:
445DK
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010951781
NSN
6505-01-095-1781
445DK
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010951781
NSN
6505-01-095-1781
MFG
ORGANON USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS SUCCINYLCHOLINE CHLORIDE PER MILLILITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PRESERVED WITH BENZYL ALCOHOL
Related Searches:
NDC00052-0445-10
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010951781
NSN
6505-01-095-1781
NDC00052-0445-10
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010951781
NSN
6505-01-095-1781
MFG
ORGANON USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS SUCCINYLCHOLINE CHLORIDE PER MILLILITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PRESERVED WITH BENZYL ALCOHOL
Related Searches:
NDC00054-4299-31
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010953600
NSN
6505-01-095-3600
NDC00054-4299-31
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010953600
NSN
6505-01-095-3600
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 40MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00172-2907-80
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010953600
NSN
6505-01-095-3600
NDC00172-2907-80
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010953600
NSN
6505-01-095-3600
MFG
IVAX PHARMACEUTICALS INC . DIV DIVISION OF TEVA PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 40MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-0216-10
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010953600
NSN
6505-01-095-3600
NDC00378-0216-10
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010953600
NSN
6505-01-095-3600
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 40MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00603-3740-32
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010953600
NSN
6505-01-095-3600
NDC00603-3740-32
FUROSEMIDE TABLETS,USP
NSN, MFG P/N
6505010953600
NSN
6505-01-095-3600
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FUROSEMIDE TABLETS USP 40MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00045-0095-60
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505010954174
NSN
6505-01-095-4174
NDC00045-0095-60
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505010954174
NSN
6505-01-095-4174
MFG
MCNEIL PHARMACEUTICAL CO
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.150 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 12
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 3.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.010 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.20 POUNDS
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PANCRELIPASE DELAYED-RELEASE CAPSULES USP 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 20000 USP UNITS AMYLASE,4000 USP UNITS LIPASE,AND 25000 USP UNITS PROTEASE
SUPPLEMENTARY FEATURES: SOLE SOURCE ITEM FOR DOD, PANCREASE BY MCNEIL